New poll shows a strong base of Canadians overwhelmingly support controlled legal access to psilocybin-assisted therapy; Canadian Psychedelic Association responds with Memorandum of Regulatory Approval (MORA)
August 04, 2021 07:02 ET
|
Canadian Psychedelic Association
Vancouver, BC, Aug. 04, 2021 (GLOBE NEWSWIRE) -- A Nanos Research Survey released today by the Canadian Psychedelic Association (CPA) shows 82 percent of Canadians approve the use of...
Guy Goodwin joins COMPASS Pathways as Chief Medical Officer
July 29, 2021 08:30 ET
|
COMPASS Pathfinder Ltd.
COMPASS announces changes to its Executive Team London, UK – 29 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating...
Danielle Schlosser joins COMPASS Pathways from Verily Life Sciences to lead clinical innovation and therapist training
July 21, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
London, UK – 21 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
COMPASS Pathways to participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit
July 07, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
London, UK, July 07, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental...
COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK
July 05, 2021 06:00 ET
|
COMPASS Pathfinder Ltd.
London, UK – 5 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
Optimi Health Supports Patient-Focused Psilocybin Advocacy by TheraPsil
June 29, 2021 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom...
COMPASS Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences
June 08, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
LONDON, June 08, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
COMPASS Pathways plc to announce first quarter 2021 financial results on 13 May 2021
May 06, 2021 08:00 ET
|
COMPASS Pathfinder Ltd.
London, UK, May 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
COMPASS Pathways announces pricing of public offering
April 29, 2021 20:45 ET
|
COMPASS Pathfinder Ltd.
London, UK, 30 April 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based...
COMPASS Pathways launches proposed public offering
April 27, 2021 17:22 ET
|
COMPASS Pathfinder Ltd.
London, UK, April 27, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...